Evogene Ltd. (EVGN)
EVGN Stock Price Chart
Explore Evogene Ltd. interactive price chart. Choose custom timeframes to analyze EVGN price movements and trends.
EVGN Company Profile
Discover essential business fundamentals and corporate details for Evogene Ltd. (EVGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Oct 2010
Employees
117.00
Website
https://www.evogene.comCEO
Ofer Haviv CPA
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
EVGN Financial Timeline
Browse a chronological timeline of Evogene Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 May 2026
Upcoming earnings on 4 Mar 2026
Upcoming earnings on 19 Nov 2025
Earnings released on 19 Aug 2025
EPS came in at -$0.12 surpassing the estimated -$0.63 by +80.95%, while revenue for the quarter reached $884.00K , missing expectations by -4.95%.
Earnings released on 21 May 2025
EPS came in at -$0.38 surpassing the estimated -$0.63 by +39.20%, while revenue for the quarter reached $2.44M , beating expectations by +25.82%.
Earnings released on 6 Mar 2025
EPS came in at $0.06 surpassing the estimated -$0.72 by +108.33%, while revenue for the quarter reached $1.61M , missing expectations by -67.78%.
Earnings released on 21 Nov 2024
EPS came in at -$1.31 falling short of the estimated -$1.01 by -29.70%, while revenue for the quarter reached $1.80M , missing expectations by -50.46%.
Earnings released on 22 Aug 2024
EPS came in at -$1.06 falling short of the estimated -$0.12 by -783.33%, while revenue for the quarter reached $914.00K , beating expectations by +14.25%.
Stock split effective on 25 Jul 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 23 May 2024
EPS came in at -$0.80 falling short of the estimated -$0.09 by -788.89%, while revenue for the quarter reached $4.19M , beating expectations by +19.71%.
Earnings released on 7 Mar 2024
EPS came in at -$1.30 surpassing the estimated -$1.40 by +7.14%, while revenue for the quarter reached $578.00K , missing expectations by -83.49%.
Earnings released on 15 Nov 2023
EPS came in at -$0.80 surpassing the estimated -$1.70 by +52.94%, while revenue for the quarter reached $3.77M , beating expectations by +313.96%.
Earnings released on 17 Aug 2023
EPS came in at -$1.70 surpassing the estimated -$1.90 by +10.53%, while revenue for the quarter reached $654.00K , missing expectations by -37.12%.
Earnings released on 18 May 2023
EPS came in at -$1.50 surpassing the estimated -$1.60 by +6.25%, while revenue for the quarter reached $641.00K , missing expectations by -27.16%.
Earnings released on 9 Mar 2023
EPS came in at -$0.70 surpassing the estimated -$2.10 by +66.67%, while revenue for the quarter reached $660.00K , beating expectations by +4.76%.
Earnings released on 17 Nov 2022
EPS came in at -$1.60 surpassing the estimated -$2.00 by +20.00%, while revenue for the quarter reached $466.00K , beating expectations by +98.58%.
Earnings released on 31 Aug 2022
EPS came in at -$2.10 falling short of the estimated -$1.80 by -16.67%, while revenue for the quarter reached $312.00K , beating expectations by +35.26%.
Earnings released on 26 May 2022
EPS came in at -$2.00 falling short of the estimated -$1.40 by -42.86%, while revenue for the quarter reached $237.00K , missing expectations by -23.30%.
Earnings released on 10 Mar 2022
EPS came in at -$1.80 surpassing the estimated -$2.00 by +10.00%, while revenue for the quarter reached $311.00K , beating expectations by +68.72%.
Earnings released on 17 Nov 2021
EPS came in at -$1.90 falling short of the estimated -$1.70 by -11.76%, while revenue for the quarter reached $151.00K , missing expectations by -44.07%.
Earnings released on 11 Aug 2021
EPS came in at -$1.50 falling short of the estimated -$0.18 by -733.33%, while revenue for the quarter reached $135.00K , missing expectations by -55.00%.
Earnings released on 26 May 2021
EPS came in at -$1.70 falling short of the estimated -$0.18 by -844.44%, while revenue for the quarter reached $333.00K , missing expectations by -5.26%.
Earnings released on 3 Mar 2021
EPS came in at -$2.50 falling short of the estimated -$0.17 by -1.37K%, while revenue for the quarter reached $351.00K .
Earnings released on 18 Nov 2020
EPS came in at -$1.70 , while revenue for the quarter reached $316.00K .
EVGN Stock Performance
Access detailed EVGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.